Located in the incubator of the Institute of Regenerative Medicine and Biotherapies (IRMB) at CHU-Saint-Éloi in Montpellier, MedXCell NKar promotes research (NKab technology) resulting from a maturation program supported by SATT AxLR. In this context, MedXCell NKar has signed two operating contracts with SATT AxLR for the development and commercial exploitation of the NKab technology.